Cairo – Mubasher: Ibnsina Pharma recorded net profits of EGP 104.75 million in the first half (H1) of 2021, an increase of 17.7% year-on-year (YoY) from EGP 88.9 million.
The company's sales grew to EGP 10.12 billion in the January-June period from EGP 8.87 billion in the corresponding period a year earlier, according to a bourse disclosure on Sunday.
Moreover, the standalone net profits rose to EGP 106.71 million in H1-21 from EGP 88.98 million in H1-20.
In the first quarter (Q1) of 2021, Ibnsina Pharma posted net profits of EGP 50.37 million, slightly up from EGP 50.27 million in the prior-year period.
